Department of Medicine

August 8, 2023

Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

By Tom Wilemon
Mary Philip, MD, PhD, left, and Michael Rudloff, PhD, found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional. (photo by Anthony Czelusniak)
August 3, 2023

Study finds hallmarks of T cell exhaustion within hours of tumor exposure

Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

By Leigh MacMillan
August 2, 2023

VUMC receives $28 million to lead national study of COVID-diabetes link

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.

By Bill Snyder
July 26, 2023

International workgroup of geneticists issues CHEK2 guidelines

International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.

By Tom Wilemon
July 26, 2023

Nancy Cox receives American Society of Human Genetics Leadership Award

Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics.

By Bill Snyder
July 26, 2023

Chase Hendrickson named executive medical director of the Medicine Patient Care Center

Chase Hendrickson, MD, MPH, has been named executive medical director of the Medicine Patient Care Center.

By Kathy Whitney
July 25, 2023

Signaling pathways in liposarcomas

A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target.
By Leigh MacMillan
July 20, 2023

Reception honors Gordon Bernard’s decades of service and contributions

Gordon Bernard, MD, was honored at a reception on July 19 in recognition of his contributions to Vanderbilt University Medical Center for more than 40 years.
By VUMC News and Communications
July 20, 2023

Predicting gene expression may speed discovery: study

Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.
By Bill Snyder
July 19, 2023

Holowatyj receives National Cancer Institute MERIT Award

Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.
By Tom Wilemon
July 18, 2023

VUMC receives $7 million award from PCORI to compare breathing tube sedation

Vanderbilt University Medical Center has received a $7 million, five-year funding award from the Patient-Centered Outcomes Research Institute to compare two sedatives used to place breathing tubes in the emergency department or intensive care unit.
By Nancy Humphrey
July 17, 2023

Academy for Excellence in Education elects 13 new members

Vanderbilt University Medical Center's Academy for Excellence in Education has elected 13 new members for 2023.
By Doug Campbell
July 14, 2023

Study uses statistical and population-based methods to understand comorbidities of developmental language disorder

A recent Vanderbilt study is one of the first to use statistical and population-based methods to understand comorbidities associated with developmental language disorder at a population level.
By Danny Bonvissuto
1 … 15 16 17 18 19 … 116